LENSAR (LNSR) Price & Analysis

Compare

71 Followers

LNSR Stock Chart & Stats

Day’s Range― - ―

52-Week Range$4.20 - $17.31

Previous CloseN/A

Volume40.10K

Average Volume (3M)65.42K

Market Cap

$151.69M

Enterprise Value$153.02M

Total Cash (Recent Filing)$20.31M

Total Debt (Recent Filing)$2.33M

Price to Earnings (P/E)―

Beta0.86

Next Earnings

Nov 06, 2025

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-0.15

Shares Outstanding11,934,784

10 Day Avg. Volume70,236

30 Day Avg. Volume65,416

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

P/FCF RatioN/A

Enterprise Value/Market Cap1.01

Enterprise Value/Revenue2.62

Enterprise Value/Gross Profit5.56

Enterprise Value/Ebitda-12.71

Forecast

1Y Price Target

$11.50

Price Target Upside-5.27% Downside

Rating ConsensusHold

Number of Analyst Covering0

Bulls Say, Bears Say

Bulls Say

AcquisitionThe announced acquisition by Alcon is seen as a positive outcome for both Lensar and Alcon, with Lensar experiencing strong adoption of its ALLY System in the cataract surgery market.

Market ExpansionLNSR highlighted that ~75% of US FY24 placements have come from new customers, indicating strong market expansion and competitive positioning.

Bears Say

Fair ValuationThe stock is rated as Neutral because the implied takeout value is seen as fairly valued, indicating limited upside potential.

Growth ChallengesLensar is required to achieve substantial procedure growth to meet the terms of the acquisition agreement, which may pose challenges.

LENSAR News

Needham medtech & diagnostics analysts hold analyst/industry conference call

Med Tech & Diagnostics Analysts Saxon and Matson, along with Dr. Yuna Rapoport of Manhattan Eye, provide a...

17d ago

ALC

JNJ

Lensar Inc. Reports Growth Amid Merger Progress

Lensar Inc ( ($LNSR) ) has released its Q2 earnings. Here is a breakdown of the information Lensar...

2M ago

LNSR

Lensar reports Q2 EPS (15c) vs (79c) last year

Reports Q2 revenue $13.935M vs $12.636M last year. “Our second quarter results reflect the continued, strong momentum of...

2M ago

LNSR

LENSAR Stockholders Approve Merger with Alcon Research

LENSAR ( ($LNSR) ) has issued an update. On July 2, 2025, LENSAR, Inc. held a virtual special...

3M ago

LNSR

FTC Extends Waiting Period for LENSAR Merger

LENSAR ( ($LNSR) ) just unveiled an update. On March 23, 2025, LENSAR, Inc. entered into a merger...

4M ago

LNSR

LENSAR Announces Merger with Alcon Research

New activity is brewing for LENSAR ( ($LNSR) ). The company has submitted a Form DEFM14A to the...

4M ago

LNSR

LENSAR Reports Strong Q1 2025 Growth Amid Merger Plans

Lensar Inc ( ($LNSR) ) has released its Q1 earnings. Here is a breakdown of the information Lensar...

5M ago

LNSR

Lensar reports Q1 EPS ($2.32) vs. (19c) last year

Reports Q1 revenue $14.2M vs. $10.6M last year.”We had a solid start to 2025, as we successfully placed...

5M ago

LNSR

Lensar downgraded to Hold from Buy at Lake Street

Lake Street analyst Frank Takkinen downgraded Lensar (LNSR) to Hold from Buy with a price target of $15,...

6M ago

LNSR

Lensar downgraded to Neutral from Buy at BTIG

BTIG downgraded Lensar (LNSR) to Neutral from Buy following the announcement that Alcon (ALC) agreed to acquire the...

6M ago

LNSR

Morning Movers: 23andMe plummets after Chapter 11 proceedings and CEO exit

Stock index futures are experiencing a notable surge, reflecting renewed investor optimism, primarily driven by reports suggesting that...

6M ago

ALC

LENSAR Announces Merger Agreement with Alcon

LENSAR ( ($LNSR) ) just unveiled an update. On March 23, 2025, LENSAR, Inc. entered into a merger...

6M ago

LNSR

Alcon to acquire Lensar for $430M

Alcon (ALC) and Lensar (LNSR) announced the companies have entered into a definitive merger agreement through which Alcon...

6M ago

ALC

LNSR

Alcon to acquire Lensar for $14.00 per share in cash

Alcon (ALC) and LENSAR (LNSR) have entered into a definitive merger agreement through which Alcon intends to acquire...

6M ago

ALC

LNSR

LNSR FAQ

What was LENSAR’s price range in the past 12 months?

LENSAR lowest stock price was $4.20 and its highest was $17.31 in the past 12 months.

What is LENSAR’s market cap?

LENSAR’s market cap is $151.69M.

When is LENSAR’s upcoming earnings report date?

LENSAR’s upcoming earnings report date is Nov 06, 2025 which is in 41 days.

How were LENSAR’s earnings last quarter?

LENSAR released its earnings results on Aug 07, 2025. The company reported -$0.15 earnings per share for the quarter, missing the consensus estimate of -$0.019 by -$0.131.

Is LENSAR overvalued?

According to Wall Street analysts LENSAR’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does LENSAR pay dividends?

LENSAR does not currently pay dividends.

What is LENSAR’s EPS estimate?

LENSAR’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does LENSAR have?

LENSAR has 11,934,784 shares outstanding.

What happened to LENSAR’s price movement after its last earnings report?

LENSAR reported an EPS of -$0.15 in its last earnings report, missing expectations of -$0.019. Following the earnings report the stock price went down -1.458%.

Which hedge fund is a major shareholder of LENSAR?

Currently, no hedge funds are holding shares in LNSR

LENSAR Stock Smart Score

Neutral

Fundamentals

Return on Equity

-350.22%

Trailing 12-Months

Asset Growth

14.67%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

LENSAR

LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. Its LENSAR Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, procedure planning, design, and precision. The company was incorporated in 2004 and is headquartered in Orlando, Florida.